Stimulant medications commonly cause appetite suppression as a side effect, which may be therapeutically beneficial for some ADHD patients but can also lead to inadequate nutritional intake
the product catalog extends well beyond GLP-1s to include hormone therapy, peptides, NAD+ injections, sexual health, dermatology, mental health, and nutritional formulations
A broader review of real-world evidence puts first-year discontinuation across studies in the range of 20% to 50%, with real-world weight outcomes generally falling below trial results, except among the most adherent patients, whose outcomes approach what trials reported
Journal of Clinical Endocrinology & Metabolism , 89(7), 3543-3553
ViaCytes VC-02 product (phase 1/2, NCT03163511) demonstrated proof-of-concept for graft survival and C-peptide production in some patients, but inconsistent engraftment and fibrotic encapsulation have hampered insulin output [138]